Nic Horridge was recently appointed president of Roche Korea, having spent an extended period in emerging Asian markets. He shares his vision for the Korean affiliate, focused on bringing Roche’s extensive global pipeline of innovative medicines to Korean patients, making personalized healthcare a reality in clinics and championing Korea as a global R&D site at the global level.
Roche and healthcare authorities are philosophically aligned as we share the same concern: bringing the most benefit to the patients we serve. Thus, our main imperative is demonstrating the benefit and value of our drugs
